AGIO
Price
$25.24
Change
+$0.67 (+2.73%)
Updated
Nov 21 closing price
Capitalization
1.47B
81 days until earnings call
Intraday BUY SELL Signals
ATHA
Price
$4.61
Change
+$0.07 (+1.54%)
Updated
Nov 21 closing price
Capitalization
18.16M
Intraday BUY SELL Signals
Interact to see
Advertisement

AGIO vs ATHA

Header iconAGIO vs ATHA Comparison
Open Charts AGIO vs ATHABanner chart's image
Agios Pharmaceuticals
Price$25.24
Change+$0.67 (+2.73%)
Volume$3.64M
Capitalization1.47B
Athira Pharma
Price$4.61
Change+$0.07 (+1.54%)
Volume$28.37K
Capitalization18.16M
AGIO vs ATHA Comparison Chart in %
AGIO
Daily Signal:
Gain/Loss:
ATHA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AGIO vs. ATHA commentary
Nov 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a Hold and ATHA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 23, 2025
Stock price -- (AGIO: $25.24 vs. ATHA: $4.61)
Brand notoriety: AGIO and ATHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 319% vs. ATHA: 78%
Market capitalization -- AGIO: $1.47B vs. ATHA: $18.16M
AGIO [@Biotechnology] is valued at $1.47B. ATHA’s [@Biotechnology] market capitalization is $18.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $108.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 0 FA rating(s) are green whileATHA’s FA Score has 1 green FA rating(s).

  • AGIO’s FA Score: 0 green, 5 red.
  • ATHA’s FA Score: 1 green, 4 red.
According to our system of comparison, both AGIO and ATHA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 5 TA indicator(s) are bullish while ATHA’s TA Score has 6 bullish TA indicator(s).

  • AGIO’s TA Score: 5 bullish, 5 bearish.
  • ATHA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, ATHA is a better buy in the short-term than AGIO.

Price Growth

AGIO (@Biotechnology) experienced а -42.18% price change this week, while ATHA (@Biotechnology) price change was +1.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -3.31%, and the average quarterly price growth was +62.87%.

Reported Earning Dates

AGIO is expected to report earnings on Feb 12, 2026.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGIO($1.47B) has a higher market cap than ATHA($18.2M). ATHA YTD gains are higher at: -21.510 vs. AGIO (-23.189). ATHA has higher annual earnings (EBITDA): -56.92M vs. AGIO (-470.31M). ATHA has less debt than AGIO: ATHA (1.02M) vs AGIO (44.5M). AGIO has higher revenues than ATHA: AGIO (44.8M) vs ATHA (0).
AGIOATHAAGIO / ATHA
Capitalization1.47B18.2M8,088%
EBITDA-470.31M-56.92M826%
Gain YTD-23.189-21.510108%
P/E Ratio3.82N/A-
Revenue44.8M0-
Total Cash953MN/A-
Total Debt44.5M1.02M4,376%
FUNDAMENTALS RATINGS
AGIO: Fundamental Ratings
AGIO
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
41
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGIOATHA
RSI
ODDS (%)
Bullish Trend 3 days ago
53%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
72%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 11 days ago
74%
Bearish Trend 10 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
70%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
AGIO
Daily Signal:
Gain/Loss:
ATHA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HWVIX12.200.38
+3.21%
Hotchkis & Wiley Sm Cp Divers Val I
NSCCX39.051.03
+2.71%
Nuveen Small-Cap Value Opps C
SWMCX14.200.27
+1.94%
Schwab ® US Mid-Cap Index
KNGYX11.470.19
+1.68%
Vest S&P500 Div Aristocrats Trgt IncY
HGISX60.890.46
+0.76%
Hartford Core Equity R4

ATHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHA has been loosely correlated with AURA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHA jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHA
1D Price
Change %
ATHA100%
+1.43%
AURA - ATHA
37%
Loosely correlated
+1.68%
MGNX - ATHA
36%
Loosely correlated
+2.19%
ALNY - ATHA
35%
Loosely correlated
-2.11%
OGEN - ATHA
35%
Loosely correlated
-1.93%
CDXS - ATHA
35%
Loosely correlated
-1.91%
More